As semaglutide-based weight loss treatments such as Ozempic and Wegovy become more popular, new side effects are emerging – ...
Affordable and alternative versions of popular weight loss drugs like Ozempic and Wegovy may no longer be available. The FDA ...
Administration officials reversed a decision made during the Biden presidency that would have given millions of people access ...
President Donald Trump's administration has decided not to cover expensive, high-demand obesity treatments under the ...
While gastrointestinal issues are the most common side effects, a recent study by the University of British Columbia linked ...
Barclays has lowered its first-quarter 2025 estimates for Novo Nordisk (CSE:NOVOb) (NYSE:NVO) ahead of its Q1 2025 report, citing weaker-than-expected prescription volumes for key drugs Wegovy and ...
The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...
Novo Nordisk already has broad FDA approvals in hand for its injected semaglutide products Ozempic and Wegovy to reduce the ...
A popular weight-loss drug used by celebrities overseas has been approved by New Zealand’s medicine regulatory body, with its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results